https://www.benchtopbios.com/2023-11-19https://www.benchtopbios.com/leveraging-ai-and-ml-in-drug-rd-current-and-future-impacts-to-the-life-sciences-industry/2023-10-03https://www.benchtopbios.com/lifesci-search-podcast-episode-1/2023-03-17https://www.benchtopbios.com/regenerative-medicine-from-humacyte-off-the-shelf-human-sourced-acellular-vessels-for-traumatic-wound-repair/2023-02-10https://www.benchtopbios.com/a-brief-chat-with-erez-raphael-ceo-of-dariohealth/2023-01-06https://www.benchtopbios.com/onconova-developing-best-in-class-anti-cancer-agents-with-multi-faceted-moas/2023-01-05https://www.benchtopbios.com/a-brief-chat-with-dror-bashan-president-ceo-of-protalix-biotherapeutics-inc/2023-01-04https://www.benchtopbios.com/a-brief-chat-with-martin-welschof-ceo-of-bioinvent/2023-01-03https://www.benchtopbios.com/a-brief-chat-with-raphi-levy-cfo-of-alpha-tau-medical-ltd/2022-12-29https://www.benchtopbios.com/a-brief-chat-with-amir-london-ceo-of-kamada-ltd/2022-12-28https://www.benchtopbios.com/a-brief-chat-with-amir-london-ceo-of-kamada/2022-12-28https://www.benchtopbios.com/a-brief-chat-with-rob-etherington-president-ceo-of-clene-inc/2022-12-27https://www.benchtopbios.com/helping-the-body-help-itself-with-escharex-the-next-generation-wound-care-therapeutic-from-mediwound/2022-12-16https://www.benchtopbios.com/a-promising-new-immune-checkpoint-from-sensei-bio-vista/2022-12-13https://www.benchtopbios.com/turning-amino-acids-into-drugs-a-novel-platform-from-axcella-health/2022-12-08https://www.benchtopbios.com/lipocine-incs-formulation-for-success-oral-agents-for-cns-disorders/2022-11-17https://www.benchtopbios.com/89bio-aims-to-tame-nash-and-severe-hypertriglyceridemia-shtg-with-lead-asset-pegozafermin/2022-11-11https://www.benchtopbios.com/de-risked-oncology-targets-with-assets-from-checkpoint-therapeutics/2022-11-04https://www.benchtopbios.com/deep-transcranial-magnetic-stimulation-deep-tmstm-brainsways-innovative-and-non-invasive-therapy-for-major-depressive-disorder-anxious-depression-ocd-and-smoking-addiction/2022-10-20https://www.benchtopbios.com/an-oncology-update-on-cdk-29-inhibition-cyclacel-pharmaceuticals/2022-09-29https://www.benchtopbios.com/oncology-on-the-moveartios-financing-considerations-for-an-early-biotech/2022-09-19https://www.benchtopbios.com/fire-up-the-immune-system-to-lead-the-charge-against-cancer-alligator-biosciences/2022-09-15https://www.benchtopbios.com/esperion-therapeutics-a-small-company-with-a-big-heart/2022-09-09https://www.benchtopbios.com/patient-centric-physician-managed-healthcare-centers-that-payers-love-p3-health-partners/2022-09-09https://www.benchtopbios.com/two-oncology-assets-in-the-clinic-and-a-sought-after-discovery-platform-ryvu-therapeutics/2022-08-04https://www.benchtopbios.com/advances-in-gene-therapy-delivery-a-non-viral-pdna-platform-that-harnesses-the-power-of-il-10/2022-07-29https://www.benchtopbios.com/a-pioneer-of-parp-inhibition-has-a-new-dna-damage-repair-ddr-platform/2022-07-26https://www.benchtopbios.com/teclisons-cancer-immunotherapy-enhancer-tec-001-shows-efficacy-in-all-cause-hepatic-tumors/2022-07-15https://www.benchtopbios.com/ibreathe-it-in-inhalable-drug-delivery-with-the-isperse-platform-from-pulmatrix/2022-07-11https://www.benchtopbios.com/p53-reactivation-via-mdm2-inhibition-with-milademetan-phase-3-data-in-1h-2023-rain-therapeutics-1/2022-07-11https://www.benchtopbios.com/p53-reactivation-via-mdm2-inhibition-with-milademetan-phase-3-data-in-1h-2023-rain-therapeutics/2022-07-07https://www.benchtopbios.com/an-anti-pd-l1-antibody-given-subcutaneously-envafolimab-by-tracon-pharma/2022-07-01https://www.benchtopbios.com/two-conditions-one-drug-working-to-relieve-chronic-cough-in-ipf-and-debilitating-itch-in-prurigo-nodularis-with-the-opioid-receptor-targeting-drug-haduvio/2022-06-27https://www.benchtopbios.com/special-delivery-platforms-ph-activated-and-sting-activating-polymeric-micelles-from-onconano-medicine/2022-06-23https://www.benchtopbios.com/phase-ii-poc-for-immuteps-lag-3-drug-eftilagimod-alpha-asco-data-and-an-introduction-to-ceo-marc-voigt/2022-06-22https://www.benchtopbios.com/inducing-immune-tolerance-in-autoimmunity-gene-therapy-and-beyond-the-immtor-platform-from-selecta-biosciences/2022-06-17https://www.benchtopbios.com/dosing-more-than-skin-deep-a-transdermal-drug-delivery-platform-from-dyve-biosciences/2022-06-10https://www.benchtopbios.com/location-location-location-delivering-your-io-asset-directly-to-the-lymph-node-with-amphiphile/2022-05-13https://www.benchtopbios.com/making-sure-theres-not-a-dry-eye-in-the-house-with-tyrvaya-from-oyster-point-pharma/2022-05-06https://www.benchtopbios.com/the-sweet-spot-and-the-market-between-the-adaptive-innate-immune-response-allogeneic-natural-killer-t-cells-nkt-from-athenex/2022-04-22https://www.benchtopbios.com/a-rare-disease-opportunity-amolyt-pharma-targeting-orphan-diseases-of-the-endocrine-system/2022-04-14https://www.benchtopbios.com/a-clinical-stage-biotech-company-developing-a-targeted-oral-small-molecule-for-synergistic-combinations-with-soc-thats-cardiff-oncology/2022-03-25https://www.benchtopbios.com/todays-oncology-play-global-reach-clinical-stage-assets-and-a-revenue-stream-antengene/2022-03-18https://www.benchtopbios.com/dyadic-international-helping-to-produce-biologic-vaccines-and-drugs-rapidly-in-large-quantities-and-at-low-cost-for-a-global-population/2022-03-10https://www.benchtopbios.com/differentiated-delivery-with-dpx-a-versatile-technology-for-immuno-oncology-by-imv-inc/2022-03-02https://www.benchtopbios.com/developing-drugs-for-rare-diseases-pointers-and-pitfalls/2022-02-28https://www.benchtopbios.com/targeting-cancer-and-fibrosis-galecto-aims-to-help-patients-with-their-first-in-class-small-molecule-drugs-in-clinical-development/2022-02-23https://www.benchtopbios.com/mapping-neoantigens-in-cancer-with-genoceas-atlas-what-to-include-and-what-to-avoid-in-your-cancer-therapy/2022-02-17https://www.benchtopbios.com/every-tumor-is-a-deadly-frontier-and-to-survive-it-you-need-a-personalized-therapeutic-path-forward-enter-the-ai-centric-guidance-of-evaxions-pioneer/2022-02-11https://www.benchtopbios.com/water-water-everywhere-innovations-in-treating-diuretic-resistant-fluid-overload-sequana-medical/2022-01-20https://www.benchtopbios.com/modulation-of-nmda-receptors-for-pain-and-cns-disorders-the-middle-way-thats-aptinyx/2022-01-14https://www.benchtopbios.com/immatics-engineering-the-right-t-cell-receptor-for-shared-tumor-associated-targets/2022-01-05https://www.benchtopbios.com/captor-therapeutics-top-grades-for-degrading-pathologic-proteins-in-oncology-and-autoimmune-disease-captor-therapeutics/2021-12-17https://www.benchtopbios.com/discovery-platform-for-small-molecule-mrna-drugs-like-no-other-mrna-lightning-from-anima-biotech/2021-12-09https://www.benchtopbios.com/seeing-clearly-where-the-sun-dont-shine-a-game-changing-technology-in-gi-endoscopy-from-motus-gi/2021-12-02https://www.benchtopbios.com/gbs-inc-a-saliva-test-for-diabetes-monitoring-an-inside-look-at-the-glucose-biosensor-technology/2021-11-14https://www.benchtopbios.com/lean-and-mean-outsourcing-oncology-machine-anixa-biosciences-inc/2021-11-11https://www.benchtopbios.com/noxxon-targeting-the-chemokines-of-the-tme-to-enhance-cancer-therapies/2021-11-04https://www.benchtopbios.com/femasys-inc-putting-the-focus-on-womens-reproductive-health/2021-10-28https://www.benchtopbios.com/to-find-the-best-antigens-for-cancer-or-covid-gritstone-bio-has-the-edgetm/2021-10-22https://www.benchtopbios.com/vincerx-pharma-from-pharmacyclics-to-cyclins-the-will-and-the-way/2021-10-08https://www.benchtopbios.com/angion-biomedica-corp-podcast-episode/2021-09-29https://www.benchtopbios.com/experience-passion-and-a-plan-vera-therapeutics-dr-marshall-fordyce-takes-us-from-the-bedside-to-the-boardroom-in-his-mission-to-treat-autoimmune-disease/2021-09-24https://www.benchtopbios.com/a-promising-repurpose-tenax-therapeutics-tests-the-cancer-drug-imatinib-in-pulmonary-arterial-hypertension/2021-09-17https://www.benchtopbios.com/medicenna-therapeutics-reining-in-the-fire-taming/2021-09-09https://www.benchtopbios.com/immutep-no-longer-left-behind-lag-3-hits-1/2021-08-27https://www.benchtopbios.com/immutep-no-longer-left-behind-lag-3-hits/2021-08-27https://www.benchtopbios.com/compugen-pioneering-dnam-axis-in-cancer-tigit/2021-08-20https://www.benchtopbios.com/hervs-and-nerves-targeting-the-viral-origins/2021-08-13https://www.benchtopbios.com/are-inkt-cells-the-next/2021-08-06https://www.benchtopbios.com/pixium-vision-sa-an-eye/2021-07-29https://www.benchtopbios.com/arcellx-plug-and-play-car-t-modular-immunotherapy/2021-07-23https://www.benchtopbios.com/a-time-for-cocktails-polytope-a-treatment-for-covid-19/2021-07-13https://www.benchtopbios.com/getting-the-bugs-out-of-alzheimers-a-new-therapeutic-approach/2021-06-30https://www.benchtopbios.com/switching-it-up-medigene-charts-a-new-course/2021-06-28https://www.benchtopbios.com/cancer-treatment-goes-viral-featuring-dr-matt-coffey-ceo-oncolytics-biotech/2021-06-18https://www.benchtopbios.com/biomx-a-real-phage-turner/2021-06-04https://www.benchtopbios.com/nk-cell-biology-longer-stands-for-not-known/2021-05-12https://www.benchtopbios.com/categories/science/2021-03-08https://www.benchtopbios.com/categories/life-sciences/2021-03-08https://www.benchtopbios.com/follow/2023-11-19https://www.benchtopbios.com/episodes/2023-11-19https://www.benchtopbios.com/reviews/2023-11-19https://www.benchtopbios.com/contact/2023-11-19https://www.benchtopbios.com/about/2023-11-19https://www.benchtopbios.com/videos/2023-11-19https://www.benchtopbios.com/rate/2023-11-19https://www.benchtopbios.com/categories/2023-11-19https://www.benchtopbios.com/podroll/2023-11-19https://www.benchtopbios.com/newsletter/2023-11-19https://www.benchtopbios.com/voicemail/popup/2023-11-19